JP2019500030A5 - - Google Patents

Download PDF

Info

Publication number
JP2019500030A5
JP2019500030A5 JP2018526787A JP2018526787A JP2019500030A5 JP 2019500030 A5 JP2019500030 A5 JP 2019500030A5 JP 2018526787 A JP2018526787 A JP 2018526787A JP 2018526787 A JP2018526787 A JP 2018526787A JP 2019500030 A5 JP2019500030 A5 JP 2019500030A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid vector
vector according
retroviral
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018526787A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019500030A (ja
JP7110096B2 (ja
Filing date
Publication date
Priority claimed from GBGB1520764.0A external-priority patent/GB201520764D0/en
Priority claimed from GBGB1609354.4A external-priority patent/GB201609354D0/en
Application filed filed Critical
Priority claimed from PCT/EP2016/078334 external-priority patent/WO2017089307A1/en
Publication of JP2019500030A publication Critical patent/JP2019500030A/ja
Publication of JP2019500030A5 publication Critical patent/JP2019500030A5/ja
Application granted granted Critical
Publication of JP7110096B2 publication Critical patent/JP7110096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018526787A 2015-11-24 2016-11-21 レトロウイルス産生のための一時的トランスフェクション法 Active JP7110096B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1520764.0A GB201520764D0 (en) 2015-11-24 2015-11-24 Transient transfection method for retroviral production
GB1520764.0 2015-11-24
GBGB1609354.4A GB201609354D0 (en) 2016-05-26 2016-05-26 Transient transfection method for retroviral production
GB1609354.4 2016-05-26
PCT/EP2016/078334 WO2017089307A1 (en) 2015-11-24 2016-11-21 Transient transfection method for retroviral production

Publications (3)

Publication Number Publication Date
JP2019500030A JP2019500030A (ja) 2019-01-10
JP2019500030A5 true JP2019500030A5 (OSRAM) 2020-01-09
JP7110096B2 JP7110096B2 (ja) 2022-08-01

Family

ID=57348703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018526787A Active JP7110096B2 (ja) 2015-11-24 2016-11-21 レトロウイルス産生のための一時的トランスフェクション法

Country Status (15)

Country Link
US (2) US10450574B2 (OSRAM)
EP (1) EP3380605A1 (OSRAM)
JP (1) JP7110096B2 (OSRAM)
KR (1) KR102067352B1 (OSRAM)
CN (1) CN108291211A (OSRAM)
AU (1) AU2016359838B2 (OSRAM)
BR (1) BR112018010639A2 (OSRAM)
CA (1) CA3006285A1 (OSRAM)
DE (1) DE102016122317A1 (OSRAM)
FR (1) FR3044017B1 (OSRAM)
IL (1) IL259223B (OSRAM)
IT (1) IT201600117287A1 (OSRAM)
RU (1) RU2749717C2 (OSRAM)
SA (1) SA518391585B1 (OSRAM)
WO (1) WO2017089307A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2856901T3 (es) * 2015-05-15 2021-09-28 Flash Therapeutics Partícula retrovírica que contiene al menos dos ARN no víricos encapsidados diferentes
JP7098521B2 (ja) * 2015-11-24 2022-07-11 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド レトロウイルス産生のための安定な細胞株
GB201706121D0 (en) * 2017-04-18 2017-05-31 Glaxosmithkline Ip Dev Ltd Stable cell lines for retroviral production
GB201715052D0 (en) 2017-09-19 2017-11-01 Oxford Genetics Ltd Vectors
EP3502260A1 (en) * 2017-12-22 2019-06-26 Oxford BioMedica (UK) Limited Retroviral vector
GB201816919D0 (en) * 2018-10-17 2018-11-28 Glaxosmithkline Ip Dev Ltd Adeno-associated viral vector producer cell lines
CN110684804B (zh) * 2019-10-15 2023-04-18 上海本导基因技术有限公司 递送外源rnp的慢病毒载体及其制备方法
GB202004371D0 (en) 2020-03-26 2020-05-13 Glaxosmithkline Ip Dev Ltd CAR constructs
GB202005096D0 (en) 2020-04-07 2020-05-20 Glaxosmithkline Modified vectors for production of retrovirus
AU2021253701B2 (en) * 2020-04-10 2024-05-02 Southwest Research Institute Three-dimensional bioreactor for viral vector production
CN118638226A (zh) 2021-03-19 2024-09-13 葛兰素史密斯克莱知识产权发展有限公司 靶向密蛋白3的嵌合抗原受体和治疗癌症的方法
CN113373266B (zh) * 2021-06-22 2022-07-01 内蒙古农业大学 一种用于检测绵羊肺腺瘤病毒的荧光rpa引物、试剂盒和检测方法
WO2024218341A1 (en) 2023-04-19 2024-10-24 Glaxosmithkline Intellectual Property Development Limited Cytotoxicity targeting chimeras for car-t and car-nk cells
WO2024218345A1 (en) 2023-04-21 2024-10-24 Glaxosmithkline Intellectual Property Development Limited Cytotoxicity targeting chimeras for antibody-drug conjugates and bispecific antibodies

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
WO1995003400A1 (en) * 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
UA65525C2 (en) * 1995-06-27 2004-04-15 Bavarian Nordic As Capsules containing encapsulated cells, method for their preparation
EP0880595A1 (en) 1996-02-13 1998-12-02 Fred Hutchinson Cancer Research Center 10a1 retroviral packaging cells and uses thereof
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
US6277621B1 (en) 1998-02-26 2001-08-21 Medigene, Inc. Artificial chromosome constructs containing foreign nucleic acid sequences
WO2000039303A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Modified hiv env polypeptides
EP1179083A4 (en) 1999-04-22 2003-04-23 Gen Hospital Corp TRIPLE HYBRID AMPLICON VECTOR SYSTEMS FOR THE PRODUCTION OF RETROVIRUS PACKING CELL LINES
US6677155B1 (en) 1999-04-22 2004-01-13 The General Hospital Corporation Triple hybrid amplicon vector systems to generate retroviral packaging lines
AU4559800A (en) 1999-04-29 2000-11-17 Aarhus Universitet Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2000075299A1 (en) 1999-06-07 2000-12-14 Cell Genesys, Inc. Hybrid yeast-bacteria cloning system and uses thereof
AU784910B2 (en) 1999-10-12 2006-07-27 Centre National De La Recherche Scientifique Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA
AU2001265187A1 (en) 2000-05-30 2001-12-11 Baylor College Of Medicine Chimeric viral vectors for gene therapy
WO2002022663A2 (en) 2000-09-18 2002-03-21 Maxygen, Inc. Stress resistant retroviruses
US6586251B2 (en) * 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
WO2002053576A1 (en) 2001-01-05 2002-07-11 The General Hospital Corporation Viral delivery system for infectious transfer of large genomic dna inserts
DE10111433A1 (de) 2001-03-09 2002-09-19 Bundesrepublik Deutschland Let Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen
BR0209989A (pt) 2001-05-30 2005-04-12 Chromos Molecular Systems Inc Plataformas baseadas em cromossomas
US6835568B2 (en) 2001-10-30 2004-12-28 Virxsys Corporation Regulated nucleic acid expression system
ES2411981T3 (es) 2002-02-01 2013-07-09 Oxford Biomedica (Uk) Limited Vector lentivírico
EP1495125B1 (en) 2002-04-10 2010-06-16 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vac-bac shuttle vector system
UA85379C2 (ru) * 2002-11-25 2009-01-26 Бавариан Нордик А/С Рекомбинантный поксвирус, содержащий как минимум два ati промотора коровьей оспы
CN1965086B (zh) * 2004-04-28 2012-12-26 宾夕法尼亚大学托管会 多价病毒载体和产生它的系统
US20080226677A1 (en) 2004-05-06 2008-09-18 Yasuko Mori Recombinant virus vector for gene transfer into lymphoid cells
EP1652932A1 (en) 2004-11-02 2006-05-03 GBF Gesellschaft für Biotechnologische Forschung mbH Method for the generation of virus producing cell lines and cell lines
AU2005309485A1 (en) 2004-11-24 2006-06-01 Nanovector Limited Viral vectors
JP4989231B2 (ja) * 2004-11-24 2012-08-01 株式会社アネロファーマ・サイエンス 新規シャトルベクター
WO2008115199A2 (en) 2006-08-18 2008-09-25 The University Of North Carolina At Chapel Hill Chimeric virus vaccines
GB0702695D0 (en) 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
WO2008118820A2 (en) 2007-03-23 2008-10-02 Wisconsin Alumni Research Foundation Somatic cell reprogramming
WO2009146150A2 (en) 2008-04-04 2009-12-03 University Of Miami Viral recombineering and uses thereof
HRP20140392T1 (hr) 2010-09-02 2014-06-06 Molmed Spa Stabilna proizvodnja lentiviralnih vektora
US9273324B2 (en) 2010-12-05 2016-03-01 Andrew S. Belmont Recombinant gene expression
WO2012170431A2 (en) 2011-06-06 2012-12-13 Bluebird Bio, Inc. Improved geneswitch systems
GB201202516D0 (en) 2012-02-13 2012-03-28 Ucl Business Plc Materials and methods relating to packaging cell lines
WO2014043131A1 (en) 2012-09-14 2014-03-20 The Regents Of The University Of California Lentiviral vector for stem cell gene therapy of sickle cell disease
JP6737714B2 (ja) * 2014-03-14 2020-08-12 ユニヴァーシティ オブ ワシントン ゲノムインスレーターエレメントおよびその使用
GB2538321A (en) 2015-05-15 2016-11-16 Glaxosmithkline Ip Dev Ltd Artificial chromosome for retroviral production
GB2538324A (en) 2015-05-15 2016-11-16 Glaxosmithkline Ip Dev Ltd Packaging cell line for retroviral production
KR102058113B1 (ko) * 2015-11-23 2019-12-23 주식회사 엘지화학 접착력이 개선된 리튬 이차전지용 전극 및 이의 제조방법
JP7098521B2 (ja) 2015-11-24 2022-07-11 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド レトロウイルス産生のための安定な細胞株

Similar Documents

Publication Publication Date Title
JP2019500030A5 (OSRAM)
JP2018534937A5 (OSRAM)
RU2018118964A (ru) Способ временной трансфекции для продуцирования ретровируса
ES2959326T3 (es) Líneas celulares estables para producción retroviral
CA3120282A1 (en) Fusosome compositions for hematopoietic stem cell delivery
JP6878620B2 (ja) レトロウイルス産生のための安定な細胞株
JP2023513303A (ja) レンチウイルスベクターの製造
JP2023504593A (ja) 産生系
GB2538321A (en) Artificial chromosome for retroviral production
GB2538324A (en) Packaging cell line for retroviral production
WO2022258967A9 (en) Lentiviral vector
US20230151388A1 (en) Modified vectors for production of retrovirus
CN117677706A (zh) 慢病毒载体
WO2024038266A1 (en) Envelope proteins
CN116218880A (zh) 一种提高病毒滴度的重组载体及其制备方法和应用
GB2544891A (en) Transient transfection method for retroviral production